# Lacosamide in Neonatal Status Epilepticus

> **NCT05291455** · PHASE3 · UNKNOWN · sponsor: **Sherief Abd-Elsalam** · enrollment: 60 (estimated)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** Lacosamide
- **DRUG:** Phenobarbital

## Key facts

- **NCT ID:** NCT05291455
- **Lead sponsor:** Sherief Abd-Elsalam
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03-01
- **Primary completion:** 2024-03-01
- **Final completion:** 2024-04-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2022-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05291455

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05291455, "Lacosamide in Neonatal Status Epilepticus". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05291455. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*